MORE VIDEOS
Explore more

Leukemia - Acute Myeloid - AML

“Improving outcomes in Acute Myeloid Leukemia” by Benjamin K. Tomlinson, MD
“Improving outcomes in Acute Myeloid Leukemia” by Benjamin K. Tomlinson, MD administrator 0 Views • 2 years ago

Grand Round presentation at University Hospitals Cleveland Medical Center and Case Western Reserve University School of Medicine, Department of Medicine on “Improving outcomes in Acute Myeloid Leukemia” by Benjamin K. Tomlinson, MD.
Dr Irene Roberts on Increased Risk of Leukemia in Patients With Down Syndrome
Dr Irene Roberts on Increased Risk of Leukemia in Patients With Down Syndrome administrator 1 Views • 2 years ago

Patients with Down syndrome are at an increased risk for developing leukemia, but how much of an increased risk depends on age, explained Irene Roberts, MD, professor of pediatric hematology, MRC molecular hematology unit and pediatrics, MRC Weatherall Institute of Molecular Medicine.
NK Cell Developmental Defects in Acute Myeloid Leukemia: Blood Drop Series at ASH-a-Palooza 2019
NK Cell Developmental Defects in Acute Myeloid Leukemia: Blood Drop Series at ASH-a-Palooza 2019 administrator 3 Views • 2 years ago

This Blood Drop video is part of a series of ignite presentations given at the American Society of Hematology’s, ASH-a-Palooza. ASH-a-Palooza is an educational experience that offers a relaxed, open learning environment for trainees with multiple opportunities for micro-learning.

https://www.hematology.org/ASH-a-Palooza

The Blood Drop presentation series covers a range of topics including hemostasis and thrombosis, sickle cell disease, ASH awards, wellness and quality improvement. Each presentation is given by an expert in their field and are presented at the event in person. If you missed any of the presentations, or the event itself, make sure to make it a part of your ASH schedule next year!

Is Chemotherapy Used For Leukemia? | Leukemia Cancer | Leukemia Diagnosis | CML Treatment
Is Chemotherapy Used For Leukemia? | Leukemia Cancer | Leukemia Diagnosis | CML Treatment administrator 0 Views • 2 years ago

#Health #ETVWin#IsChemotherapyUsedForLeukemia

Surgical Oncologist Dr Sreekanth addresses the viewer's query on requirement of chemotherapy for leukaemia. He suggests evaluating the type of leukaemia and recommends chemotherapy depending on the patient condition. Know the doctors advice on is chemotherapy used for leukemia and leukemia cancer and leukemia diagnosis and cml treatment.

To watch your ETV all channel’s programmes any where any time Download ETV Win App for both Android & IOS: https://f66tr.app.goo.gl/apps

ETV Telugu(Youtube) - http://bit.ly/2QR0yu9
Facebook - http://bit.ly/2L2GYYh

ETV Jabardasth(Youtube) - http://bit.ly/35xdqtu

ETV Dhee(Youtube) - http://bit.ly/2Ok8zWF

ETV Plus India(Youtube) - http://bit.ly/2OlEAOg
Facebook - http://bit.ly/2DudC0t

ETV Abhiruchi(Youtube) - http://bit.ly/2OkEtTb
Facebook - http://bit.ly/2OSrIhv

ETV Life(Youtube) - http://bit.ly/2OiKAY6
Facebook - http://bit.ly/34tiqzk

ETV Telangana(Youtube) - http://bit.ly/33nRaAK
Facebook - http://bit.ly/37GkVQF

ETV Andhra Pradesh(Youtube) - http://bit.ly/2OKARZz
Facebook - http://bit.ly/2R0vs3k

► Like us on Facebook : https://www.facebook.com/etvwin
► Follow us on Instagram : https://www.instagram.com/etvwin/
► Follow us on Twitter : https://twitter.com/ETV__Win
► Visit Website : https://www.etvwin.com/
► Pin us on Pinterest: https://in.pinterest.com/etv_win/

Leukemia: Signs, Symptoms, Treatment | Max Hospital
Leukemia: Signs, Symptoms, Treatment | Max Hospital administrator 1 Views • 2 years ago

Leukaemia is a cancer of the white blood cell often characterized by the uncontrolled growth of blood cells, usually white blood cells in the bone marrow.

In this video, #MaxExpert talks about Leukaemia, its causes, types, symptoms, and treatment.

Dr Esha Kaul (https://bit.ly/3i8z4jp), Associate Director - Medical Oncology (Haematology, Hemato – Oncology, BMT) at Max Super Speciality Hospital, Vaishali, explains the growth of Leukaemia, the stage of progression and its diagnosis in detail.

Watch the full video to learn more about Leukaemia and how a patient suffering from it can maintain their quality of life with an integrative treatment.

#MaxHospital #MaxHealthcare #Leukaemia #BloodCancer

*Key Moments*

0.00 - Introduction
0.28 - About Leukaemia
0.36 - Types of Leukaemia
1.35 - Treatment options for Leukaemia
2.01 - What do the different stages of Leukaemia mean?
3.13 - Leukaemia Diagnosis & Tests
4.00 – Leukaemia: Risk by age group
4.56 - Guidelines for the diagnosis of Leukaemia
6.21 - Advances in the treatment of Leukaemia
6.45 - Conclusion

Disclaimer - The information in this video was accurate as of the shoot date (05.09.2022) and upload date (29.11.2022). For information purposes only. Consult your local medical authority for advice

Follow Max Healthcare on social media to get latest updates:
https://www.facebook.com/MaxHospitalsIndia/
https://twitter.com/MaxHealthcare
https://www.linkedin.com/company/max-healthcare

Secondary Acute Myeloid Leukemias (AML)
Secondary Acute Myeloid Leukemias (AML) administrator 1 Views • 2 years ago

The panelists, Ruben A. Mesa, MD, FACP; Elias Jabbour, MD; Rafael Bejar, MD, PhD; and Rami Komrokji, MD, comment on patient features and environmental factors that may lead to the development of secondary leukemias.
Pre-leukemic stem cells: a telltale sign of AML
Pre-leukemic stem cells: a telltale sign of AML administrator 0 Views • 2 years ago

As innovative research investigating acute myeloid leukemia (AML) progresses, the chances of developing effective treatments against the ailment increase. In this video, Ravindra Majeti, MD, PhD, from Stanford University, Stanford, CA, speaking from the International Conference of Acute Myeloid Leukaemia 2017 in Estoril, Portugal by the European School of Hematology (ESH), discusses his group’s research into hemopoietic stem cells, including the mutations causing pre-leukemic stem cells and their relation to the development of AML. Dr Majeti details the various models being used to assess these genetic mutations, including the CRISPR-Cas9 system.
What Are the Latest Acute Myeloid Leukemia Therapies?
What Are the Latest Acute Myeloid Leukemia Therapies? administrator 0 Views • 2 years ago

What are the latest treatments in acute myeloid leukemia (AML)? Dr. Catherine Lai from Penn Medicine discusses the increase in available AML treatments. Learn about combination therapies and treatment options for patients with IDH1, IDH2, and FLT3 mutations.

Patient Empowerment Network (PEN) is a 501(c)(3) non-profit organization. PEN’s mission is to fortify cancer patients and care partners with the knowledge and tools to boost their confidence, put them in control of their healthcare journey, and assist them in receiving the best, most personalized care available to ensure they have the best possible outcome. Subscribe now to receive the latest news on cancer treatment and research: https://powerfulpatients.org/connect

Acute Myeloid Leukemia: Novel Therapies for Newly Diagnosed Patients - Part 2
Acute Myeloid Leukemia: Novel Therapies for Newly Diagnosed Patients - Part 2 administrator 0 Views • 2 years ago

Earn CME for related activities: https://www.naccme.com/oln

In this webcast from the 'Looking to the Future With Hope: Advances in the Treatment of AML' symposium during the 2019 Lymphoma & Myeloma conference in New York, Dr. Gail J. Roboz discusses novel targeted therapies for the treatment of newly diagnosed acute myeloid leukemia (AML).

© 2019 Imedex, an HMP Company

Molecular Profile of Acute Myeloid Leukemia (AML)
Molecular Profile of Acute Myeloid Leukemia (AML) administrator 0 Views • 2 years ago

Timothy A. Graubert, MD, Massachusetts General
Hospital Cancer Center, Harvard Medical School

Comprehensive studies of the acute myeloid leukemia (AML) genome have revealed new insights into the genetic basis of this disease. Recurrently mutated genes fall into pathways previously implicated in AML pathogenesis (e.g., cytokine signaling, line age specific transcription factors) and novel pathways (e.g., RNA splicing, epigenetic regulation, cohesin biology). This increased knowledge provides opportunities to refine prognostic algorithms and has identified new potential targets for therapy.
Showing 8 out of 9